Chinese weight-correction model for maternal serum markers in Down syndrome prenatal screening

被引:2
|
作者
Wang, Yuan-Yuan
Zhang, Li
Peng, Zuo-Qi
Cui, Qin-Zi
Ma, Xu
机构
[1] Natl Res Inst Family Planning, Beijing 100081, Peoples R China
[2] Peking Union Med Coll, Beijing, Peoples R China
[3] WHO Collaborating Ctr Res Human Reprod, Beijing, Peoples R China
[4] Sheng Yang Maternal & Child Hlth Hosp, Liaoning, Peoples R China
关键词
Down syndrome; prenatal screening; regression model; weight-correction model;
D O I
10.1016/j.ijgo.2006.11.013
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To determine the best weight-correction model by means of analyzing the relationship between maternal weight and maternal serum markers when screening for Down syndrome in China. Methods: Serum levels of (x-fetoprotein (AFP) and free beta-human chorionic gonadotropin (hCG) were measured in 35,917 Chinese women during the second semester of a normal singleton pregnancy and converted to multiple of median (MoM) values. Using 2 methods of statistical analysis, the all-point method and the median regression method, 4 weightcorrection models were then tried, the simple linear, reciprocal, quadratic, and log-linear regression models. Results: The median regression method performed better than the all-point method, and the quadratic regression model showed the best fit for both AFP and hCG in the median regression method, with adjusted R(2)s of 0.987 and 0.988, respectively. Conclusion: The quadratic regression model was found to be the most suitable for Chinese pregnant women. (c) 2006 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:21 / 25
页数:5
相关论文
共 50 条
  • [41] PROSPECTIVE SCREENING FOR DOWN SYNDROME USING MATERNAL SERUM AFP
    NELSON, MM
    PETERSEN, EM
    LANCET, 1985, 1 (8440): : 1281 - 1281
  • [42] Maternal serum screening in cases of mosaic and translocation Down Syndrome
    Dreux, Sophie
    Olivier, Camille
    Dupont, Jean-Michel
    Leporrier, Nathalie
    Oury, Jean-Francois
    Muller, Francoise
    PRENATAL DIAGNOSIS, 2008, 28 (08) : 699 - 703
  • [43] MATERNAL SERUM DOWN SYNDROME SCREENING - UNCONJUGATED ESTRIOL IS NOT USEFUL
    MACRI, JN
    KASTURI, RV
    KRANTZ, DA
    COOK, EJ
    SUNDERJI, SG
    LARSEN, JW
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 162 (03) : 672 - 673
  • [44] Maternal serum screening for fetal down syndrome: Clinical aspects
    Saller, DN
    Canick, JA
    CLINICAL OBSTETRICS AND GYNECOLOGY, 1996, 39 (04): : 783 - 792
  • [45] Down syndrome maternal serum screening in patients with renal disease
    Benachi, Alexandra
    Dreux, Sophie
    Kaddioui-Maalej, Sahar
    Czerkiewicz, Isabelle
    Fakhouri, Fadi
    Thervet, Eric
    Muller, Francoise
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2010, 203 (01) : 60.e1 - 60.e4
  • [46] Maternal serum screening for fetal Down syndrome in IVF pregnancies
    Ribbert, LSM
    Kornman, LH
    DeWolf, BTHM
    Simons, AHM
    Jansen, CAM
    Beekhuis, JR
    Mantingh, A
    PRENATAL DIAGNOSIS, 1996, 16 (01) : 35 - 38
  • [47] MATERNAL SERUM AFP AS SCREENING-TEST FOR DOWN SYNDROME
    HOULSBY, WT
    LANCET, 1984, 1 (8386): : 1127 - 1127
  • [48] Maternal serum screening for Down's syndrome on population basis
    Salonen, R
    Turpeinen, U
    Kurki, L
    Lappalainen, M
    Ammala, P
    Hiilesmaa, V
    Teramo, K
    vonKoskull, H
    Gahmberg, N
    Stenman, UH
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1997, 76 (09) : 817 - 821
  • [49] Maternal serum screening for down syndrome in Thai pregnant women
    Sangkitporn, S
    Lamlertkittikul, S
    Sangkitporn, SK
    Chandeying, V
    CLINICA CHIMICA ACTA, 2005, 355 : S316 - S316
  • [50] Maternal serum hyaluronic acid is ineffective for Down syndrome screening
    Muller, F
    Rebiffé, M
    Faina, S
    Vignal, P
    PRENATAL DIAGNOSIS, 2000, 20 (01) : 80 - 81